Literature DB >> 12628706

DNA binding of iron(II) complexes with 1,10-phenanthroline and 4,7-diphenyl-1,10-phenanthroline: salt effect, ligand substituent effect, base pair specificity and binding strength.

Karna Wijaya, Naoki Yoshioka, Hidenari Inoue.   

Abstract

The DNA binding of iron(II) mixed-ligand complexes containing 1,10-phenanthroline(phen) and 4,7-diphenyl-1,10-phenanthroline(dip), [Fe(phen)(3)](2+), [Fe(phen)(2)(dip)](2+) and [Fe(phen)(dip)(2)](2+) has been characterized by spectrophotometric titration and melting temperature measurements. The salt concentration dependence of the binding constant has allowed us to dissect the DNA-binding constant and free energy change of each iron(II) complex into the nonelectrostatic and polyelectrolyte contributions. A comparison of the nonelectrostatic components in the binding free energy changes among iron(II) complexes has made it possible to rigorously evaluate the contribution of the ligand substituents to the DNA-binding event. The peripheral substitution of phen by two phenyl groups increases the nonelectrostatic binding constant of the iron(II) complex more than 20 times, which is equivalent to approximately 7.5 kJ mol(-1) of more favorable contribution to the DNA binding. In general, the iron(II) complexes studied have higher affinity towards the more facile A-T sequence than the G-C sequence. This preferential binding may be attributed to the steric effect induced by the ancillary part of the ligands in the course of DNA binding. The binding of disubstituted iron(II) complex to DNA is quite strong as reflected in the modest increase in the denaturation temperature (T(m)) of double helical DNA upon the interaction with the iron(II) complex. Copyright 2003 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628706     DOI: 10.1016/s0162-0134(03)00007-2

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  DNA studies of newly synthesized heteroleptic platinum(II) complexes [Pt(bpy)(iip)](2+) and [Pt(bpy)(miip)](2.).

Authors:  Burak Coban; Ishak Ozel Tekin; Abdurrahman Sengul; Ufuk Yildiz; Izzet Kocak; Nergis Sevinc
Journal:  J Biol Inorg Chem       Date:  2015-12-01       Impact factor: 3.358

2.  APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency.

Authors:  Cheng-Yu Tsai; Si Sun; Hongying Zhang; Andrea Local; Yongxuan Su; Larry A Gross; William G Rice; Stephen B Howell
Journal:  Mol Cancer Ther       Date:  2018-04-06       Impact factor: 6.261

3.  Synthesis, characterization, and DNA binding of complexes [Pt(bpy)(pip)](2+) and [Pt(bpy)(hpip)] (2+).

Authors:  Burak Coban; Ufuk Yildiz; Abdurrahman Sengul
Journal:  J Biol Inorg Chem       Date:  2013-03-14       Impact factor: 3.358

4.  Hemoglobin-driven iron-directed assembly of gold nanoparticles.

Authors:  Jacquelyn G Egan; Nicole Drossis; Iraklii I Ebralidze; Holly M Fruehwald; Nadia O Laschuk; Jade Poisson; Hendrick W de Haan; Olena V Zenkina
Journal:  RSC Adv       Date:  2018-04-26       Impact factor: 4.036

5.  In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators.

Authors:  Karin Merschjohann; Dietmar Steverding
Journal:  Kinetoplastid Biol Dis       Date:  2006-08-16

6.  Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-induced DNA damage.

Authors:  Yuyang Zhou; Ying Xu; Lunjie Lu; Jingyang Ni; Jihua Nie; Jianping Cao; Yang Jiao; Qi Zhang
Journal:  Theranostics       Date:  2019-09-18       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.